Psychedelic drug MDMA faces questions for approval for PTSD therapy
WASHINGTON -- Federal well being regulators are questioning the protection and proof behind the primary bid to make use of...
approval
WASHINGTON -- Federal well being regulators are questioning the protection and proof behind the primary bid to make use of...
